PROFUSA INC (PFSA)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$0.62-0.21%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · PFSA
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -85.3% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Model as of —
PFSA — legal / regulatory event — Change in Registrant’s Certifying Accountant
Dated 2026-10-09
Change in Registrant’s Certifying Accountant. (a) Dismissal of Independent Registered Public Accounting Firm . On October 5, 2026, Profusa, Inc. (the “Company) dismissed CBIZ CPAs P.C. (“CBIZ”) as its independent registered public accounting firm. The decision to change the Company’s independent registered public accounting firm was approved by the Company’s Audit Committee and Board of Directors. CBIZ’s report on the Company’s financial statements for the fiscal year ended December 31, 2025…
Why it matters: Nasdaq said Profusa had fewer than 500,000 publicly held shares after its reverse split. Losing listing status could block the deal.
Worry ifNasdaq confirms Profusa has at least 500,000 publicly held shares and has cured the listing notice.
Less concerning ifNasdaq starts delisting steps or says Profusa failed to fix the public-share shortfall.
Why it matters: Profusa had $719,000 in cash and $28.2 million in liabilities at June 30. Recent notes add to the need for clear funding updates.
Worry ifThe November 18 report shows more cash than the June 30 balance and no new senior secured convertible note.
Less concerning ifThe report shows cash of $719,000 or less. Or it discloses another senior secured convertible note.
Why it matters: G3 reported about $111 million in estimated 2025 revenue. The option still depends on funding, debt terms, and stockholder approval.
Supportive ifProfusa files a notice that it used the G3 option after meeting the listed closing terms.
Worry ifProfusa says it did not use the option, or the option window ends without use.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$572 on $10,000 · ±5.7% | How much price usually moves either way. |
| Bad day | $3,255 loss on $10,000 · 32.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,996 loss on $10,000 · 100.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.